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orresponding arrangement that covers and safeguards the unit dose of drug is called packaging .One of 
main reason of deaths , treatment failure , un cure cases and failure of health care set up is counterfeit 
drugs. Renowned medicines brands in addition to sky-scraping cost of medicine make pharmaceutical 
ideal for counterfeit medicines and in top of list include medicine for most commonly use disease and high 
price like medicine use in dyslipidemia, anticancer antihypertensive and other antidiabetic agents. This review 
article focus on the perfect ways and features present existing anti counterfeit technologies and various other 
parameters in upcoming and how to remove draw backs in existing technologies during packaging in 
pharmaceutical industry. 
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1. INTRODUCTION 
Packaging is a connection in manufacturing of 
medicine by means of promotion through which 
medicine arrive to customers from the 
manufacturing units in a secure and  safe  way 
and state in a lowest possible rate and other 
expenditure should be in range [Kusum, Burande et 
al. 2007]. Another way to define Packaging is the 
synchronized scheme which be capable of put in or 
safeguard the medicines for delivery, store, 
maintenance, carrying, in sequence, and marketing 
[soroka fundamentals, 2002]. The medicine and 
other pharmaceutical products are more susceptible 
to counterfeit because elevated marketplace share, 
simplicity of manufacturing operations , and better 
turnover margins [Sangal and Shukla, 2009]. 
Counterfeit is a dilemma of manufactured 
medication safety. Medicines are preoccupied from 
their appropriate allocation control.  
Counterfeit is a dilemma of manufactured 
medication safety. Medicines are preoccupied from 
their appropriate allocation control, or sold 
precedent their termination time, or by alteration of 
the wrap up are connected by means counterfeiting 
[Dhar, 2010; Olsmats, 2002]. 
Counterfeits is a process in which illegal productions 
of a product which are registered legally, which are 
very much alike or indistinguishable to real products 
[Cordell, Wongtada et al. 1996; Phau , Min et al. 2009]. 
In the the very first conference on the counterfeit 
drugs held in Geneva on April 1–3, 1992 at World 
Health Organization (WHO) approved definition of 
counterfeit drugs and according to that “Counterfeit 
drugs is that is deliberately plus incorrectly labeled 
in agreement to individuality in addition to/or basis. 
Counterfeiting can be relevant jointly to together 
recognized in addition to basic medicines consisting 
of any accurate or inaccurate constituents, missing 
generic  constituents, or by bogus covering” [Ruchir, 
Prajesh et al. 2010]. afterward on, the idea was 
personalized as a result of the meeting of Nigerian 
National Agency for Food and Drug Administration 
and Control (NAFDAC) as “ drugs with the similar 
amount of generic constituents because with the 
intention of  authentic product, inadequate 
otherwise width out generic constituents, drugs  
which are after termination time , herbal products so 
as to  poisonous otherwise unproductive plus drugs 
which do not stand the producer information 
including name and full address  are also included in 
counterfeit” [Clark, 2003]. Counterfeiting is a 
technique, which causes the violation of property 
rights, medicine legislations, and other prospects of 
criminal law [Ruchir, Prajesh et al. 2010]. 
Counterfeiting and copying are in term the same as 
they both are the reproduction of similar copies of 
the original product [Phau, Min et al. 2009; 
Zaichkowsky, 1999]. Most of such counterfeit drugs 
are called lifestyle drugs in developed industrialized 
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countries. Consumers usually buy such drugs from 
internet or unauthorized pharmacies [12]. Such 
counterfeit drugs mainly caused the morbidity and 
mortality that may leads to the lack of confidence on 
healthcare system [Swaminath and Faking, 2009]. In 
India, counterfeit and copied drugs are being use 
through refill repair and reuse of products [Business 
Action to Stop Counterfeiting and Piracy (BASCAP) 
Research report, 2009]. In Europe and US, 
repackaging is one of counterfeit source [Zurich, 
2007]. It is estimated that almost 
500,000-1,000,000 people dies per year by use of 
such counterfeit products [Cockburn, 2005]. 
2. Need for anti-counterfeit technologies 
Patient safety is the main goal, which can be 
achieved by adopting approach to anti-counterfeit 
technologies. This reduces drug recalls of companies 
from markets and also prevents from legal suits. 
Moreover, the image of brand is defaced and 
consumer fears of using products of that company in 
future. 
Main strategies against counterfeiting are: liability 
suits against illegal traders, use of modern 
technologies, counseling and awareness of 
consumers and liaison with law imposing agencies. 
Among all stands the enforcement of technologies 
[Clark, 2003]. This helps in production of replica 
drugs and also enhances its production cost than 
original ones [Phau, Min et al. 2009]. Supply chains 
can be assured by governments that they should be 
free from counterfeiting, using these kind of 
technologies [Ruchir, Prajesh et al. 2010]. 
 
3. Characteristics of ideal anti-counterfeit 
technology 
These technologies should be able to possess high 
merits of security which cannot be cloned, should be 
used against wide range of products, efficient in 
standards with fast process, and may have quality of 
mechanically be authenticable, even can be used by 
consumers themselves. Most important it should be 
legally accepted by companies [Zaichkowsky, 1999]. 
But, FDA supports use of more and more 
technologies with variety of types and authenticity 
[Business insights, 2005]. 
4. Anti-counterfeit technologies 
There are three main ways to use these technologies 
which have their own merits and demerits 
[Swaminath and Faking, 2009;   Business Action to 
Stop Counterfeiting and Piracy (BASCAP) Research 
report, 2009]. These include: 
4.1 Tamper-evident/tamper-resistant packing 
Film wrappers, bands, tape seals, breakup caps, 
blister packs , shrinkable seals and many others 
technologies which may have visual signs and can be 
easily interpreted by consumers if any hampering or 
breaching has been done [Zurich, 2007]. 
4.2 Product authentication 
Signs of authenticity can be, embossed or imprinted 
or embedded on dosage forms and also on packaging, 
overt, covert markers as shown [Cockburn, 2005].
Table 1: Comparison of Authentication Characteristics.
Features Overt features Covert features Forensic features 
Examples Holograms, color-shift 
Inks 
Embedded images, digital 
watermarks, invisible printing 
Chemical and biological tags, 
microtaggants 
Advantages User verifiable, more 
secure, decorative appeal, 
low cost 
Easily added or modified, 
need regulatory approval, 
applied in-house or via 
component suppliers, low cost 
High-tech and secure against 
copying, provide positive 
authentication, may be 
disclosed for overt purposes 
Disadvantages Require user education, 
easily mimicked, rely on 
covert features for 
authentication, may be 
re-used or refilled, 
provide false assurance 
Need strict secrecy, risk of 
compromise, more secure 
options add supply 
complexity and cost 
Licensed technologies, 
significant cost, difficult to 
implement and control across 
many markets, unlikely to be 
available to authorities or 
public 
 4.3 Holograms for Anti-counterfeiting 
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To eliminate counterfeiting holograms is the best 
approach which can provide both lines of 
authentication as overt (first line) and covert  
 
(second line) for basic consumers and forensics 
respectively. The covert signs or markers include 
microtext, ultraviolent- sensitive, scrambled images 
and other specialized inks. Sometimes holograms 
are also used for effective tracing and combat against 
counterfeiting [Goldhammer and Scott, 2006; Sanjay 
and Sanjeev, 2009]. 
4.4 Track and trace technology 
In this, a unique identification number is given to 
each stock unit in manufacturing process until 
consumption of product. A secure database contains 
same code as on the product and, which contains all 
the record of product, and is kept for traceability of 
product [Europe BRIDGE consortium 
Problem-Analysis Report, 2007]. 
4.5 Mass Serialization 
The technique of creating, encoding, and verifying 
the unique identity of individual physical items called 
Serialization [International Medical Products]. 
Without it, the accuracy and validity of the purebred 
relates only to the lot number consisting of 
thousands of bottles. However, a specific bottle of a 
particular drug cannot be authenticated 
[Pharmaceutical Technology Trends, 2008]. 
Sterilization facilitates the tracking of a product 
through the supply chain and allows for targeted 
identification of products for recall [International 
Medical Products]. Global Standards one (GS1) 
develops global standards for the identification of 
goods and services and these standards are used for 
the identification of pharmaceutical products in sixty 
countries throughout the world [Tamper Stop 
Security Technology]. 
4.6 Global Trade Item Number (GTIN) 
A 14/13/12/8 digitally distinctive credentials 
number is allot by the manufacturer appropriate to 
GS1 allocation rules for trade objects or goods and 
services. It is making from a company prefix 
assigned by GS1, an item indication number 
designated by the company, and a check digit 
[Therapeutic Goods Administration Guideline]. 
Proceeding to market supplies for item-level 
serialization and verification, Astrazeneca made it as 
an internal initiative [Securing Pharma Label 
combines holograms, 2011]. 
4.7 Serialized Global Trade Item Number (sGTIN) 
A distinctive number that identify a fussy trade item, 
formed by attach a serial number to the GTIN of the 
product. In their draft guidance for serialized 
identifier prescription drugs, the FDA proposed the 
use of the NDC combined with an eight-digit serial 
number. [Therapeutic Goods Administration 
Guideline]. In March 2010, the FDA issued guidance 
deal with the package level SNI (Serialized 
Numerical Identifier) to be “applied to a 
recommendation drug at the manufacture and 
repackaging of the product to assist its track and 
trace” [US Food and Drug Administration 
Prescription Drug Marketing Act]. 
The key defy of execute serialization are the 
intricacy of data that is to be tracked, and the need 
for potentially huge, multi-access databases [Joanne 
SH]. 
4.8 Data Carriers 
Data carriers are graphical systems used to transmit 
the product identifiers and associated information in 
computer/ human comprehensible format. A mark, 
tag, or label applied at the source represents them. 
Computer readable formats include linear and two 
dimensional (2D) bar codes and radio frequency 
identifier (RFID) tags [Therapeutic Goods 
Administration Guideline]. These are the most 
commonly employed nowadays [National Chain 
Drug Stores]. 
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Table 2: Radio Frequency identifier (RFID) Vs 2 Dimensional (2D) Barcode 
Features 2D BARCODE RFID 
Direct line of sight requirement Yes No 
Difficult to duplicate or alter No Yes 
Readability robustness (interference with liquids/metals) No Yes 
Cost of tags Low High 
Tag data storage Low High 
Bulk tag reading No Yes 
Initial technology set up cost Low High 
Eco-system and/or standards maturity High Medium 
Tag feature’s extendibility (ex. Tag with sensors) Low High 
 
5. Multi-level approach 
Anti-counterfeiting technological approaches are  
Inter-reliant for their efficiency, and incorporate 
they give up a more hearty system. For this, a 
combination of evident and concealed procedures 
may give best security as they help avert 
counterfeiting and reassure end-users [Joanne SH]. 
For example, using drug product serialization in 
combination with electronic pedigree greatly 
improved the level of protection by the aptitude to 
verify both the product and the operation reliability 
[US Food and Drug Administration FDA counterfeit 
drug task force]. For example, the serialization of 
holographic labels [Joanne SH]. Some organizations 
such as Authentix and Nosco have made initiatives to 
combine the respective limitations and the potential 
of both Data Matrix and RFID, such that cases and 
pallets can be tracked with RFID tags, while 
medicines can be tracked with Data Matrix [National 
Council for Prescription Drug Programs]. yet, a 
multi-level approach may also result in further 
expenditure as the technologies become more 
complicated and should be execute based on the risk 
analysis of the drug to be counterfeited. 
6. Markets of anti-counterfeiting technologies 
BCC Research showed that the global sales of 
anti-counterfeiting packaging technologies were 
worth US $64 billion in 2010, and the worth is 
projected to be $74.2 billion in 2015. Track and  
 
 
trace technologies and authentication technologies 
made up for sales of US$31.7 and $32.4 billion 
respectively in 2010. Expected values of these by 
2015 are US$36.5 and $37.7 billion respectively [US 
Food and Drug Administration Anti-Counterfeit Drug 
Initiative Workshop and Vendor Display]. 
7. Recent technologies 
Use of isotope recipient: A current study illustrates 
the aptitude of labeled excipients in different ratios to 
provide in-product, batch-specific identification 
using existing technology in the pharmaceutical 
industry [Global Standards one Standards Save 
Lives:GS1 in Healthcare]. For acceptance in 
developing countries like India, a system named 
apothecary was anticipated which is a mobile-based 
authentication system [GS1 healthcare reference 
book 2011/2012]. A research study anticipated the 
application of semiconductor nanostructures called 
quantum dots as a promising strategy against 
counterfeiting [US Food and Drug Administration 
Standards for securing the drug supply chain]. 
8. Anti-counterfeit measures in the 
pharmaceutical industry 
Numerous anti-counterfeit technologies are being 
developed by pharmaceutical firms to avoid the 
counterfeits. A few of the products with the 
consequent anti-counterfeit measures are 
mentioned in Table. Beside with the anti-counterfeit 
technologies, the analytical techniques are in 
addition applied by pharmaceutical industries for 
authentication which are explicate in a later section.
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Table 2: Anti-counterfeit technologies used in brand pharmaceutical products [Deus DBS, 2006; Elisabeth, 
Alejandro et al. 2011] 
Pharmaceutical Company Product Active Ingredient Authentication Mark 
Pfizer Inc. Viagra† Sildenafil citrate RFID 
Hoffmann-La Roche Ltd Rocephin† Ceftrioxone sodium Logo stamps inside vials 
GlaxoSmithKline 
Pharmaceuticals Ltd 
Trizivir† Abacavir/lamivudine/zidovudine RFID 
Purdue pharma L.P. Oxycontin† Oxycodone HCl RFID 
 
9. Analytical techniques 
Verification by means of the variety of 
anti-counterfeit technologies can be done in the 
delivery sequence, whereas analytical techniques 
similar to chromatography, optical spectroscopy, and 
isotopic description prove the constituents possess 
by a drug [Business Communications Company]. A 
number of analytical methods were used by diverse 
pharmaceutical companies intended to the 
recognition of counterfeits. They comprise 
straightforward and uncomplicated methods like 
colorimetry and thin-layer chromatography, to highly 
developed techniques for example NMR, mass, and 
raman spectroscopies [Felton, Shah et al. 2011]. 
Small instruments keeps in hand are getting extra 
significance in addition to many devices are 
manufactured. Mostly moveable instruments similar 
to the handholding raman and IR spectrometers are 
frequently used due to their durability, fast, in 
addition to dependable features. An augmented order 
for these is not happen only by the medicine sector, 
other than also by health departments and 
establishment, authorities, agencies. A number of 
the facts due to such command are that these are 
fast, durable, moveable, and simple to utilize by 
ordinary worker [Michael and Chen, 2012]. 
10. Drawbacks of anti-counterfeit technologies 
Anti -Counterfeit-methods should be employed by 
shifting them frequently as they cannot  be 
reproduce by others, frequently within 12–18 
months Patients and pharmacist must have to know 
how of Varity of features and they must have 
knowledge of shifting of anti-counterfeit 
technologies  Overt and covert packaging 
technologies are rendered useless if a drug is 
repackaged [Mukherjee and Ushasi, 2011]. 
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